Position in MDCX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,195
+$3,014 QoQ
Shares Held
25,102
+40.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 23 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDCX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $3,979,998,649 across 21 Drug Manufacturers - General names. MDCX ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
945,456 | $1,134,008,383 | |
| 2 | ABBV |
AbbVie Inc.
|
3,169,783 | $797,644,194 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,480,444 | $439,719,294 | |
| 4 | JNJ |
Johnson & Johnson
|
1,500,832 | $381,166,302 | |
| 5 | AMGN |
Amgen Inc
|
703,984 | $254,926,685 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,933,667 | $248,476,209 | |
| 7 | AZN |
Astrazeneca PLC
|
970,043 | $183,939,553 | |
| 8 | PFE |
Pfizer Inc
|
6,191,186 | $149,083,758 |
All Filings in MDCX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,195 | 25,102 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,181 | 17,824 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $122,886 | 41,099 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||